Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Y. Z. Patt"'
Publikováno v:
Clinics in Liver Disease. 5:479-508
The prognosis of patients with HCC remains dismal. Even in the subgroups of patients who have the most favorable characteristics and are eligible for surgical resection, the 5-year survival rate is less than 25%. For patients with more advanced disea
Autor:
N. J. Petrelli, Y. Z. Patt, L Hammershaimb, Frederick L. Moffat, F. S. Whaley, C. M. Pinsky, David M. Goldenberg
Publikováno v:
Journal of Clinical Oncology. 14:2295-2305
PURPOSE To assess the performance and the potential clinical impact of a new antibody imaging agent, CEA-Scan (Immunomedics Inc, Morris Plains, NJ), in 210 presurgical patients with advanced recurrent or metastatic colorectal carcinomas. METHODS CEA-
Autor:
Y Z, Patt, M M, Hassan, R D, Lozano, K A, Waugh, A M, Hoque, A I, Frome, S, Lahoti, L, Ellis, J N, Vauthey, S A, Curley, I I, Schnirer, I, Raijman
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(11)
The aim of this study was to test the efficacy of a chemotherapy combination of cisplatin, IFN alpha-2b, doxorubicin, Adriamycin, and 5-fluorouracil (PIAF) as treatment for radiologically measurable cancer of the biliary tree. Forty-one patients (19
Autor:
T W, Leung, Y Z, Patt, W Y, Lau, S K, Ho, S C, Yu, A T, Chan, T S, Mok, W, Yeo, C T, Liew, N W, Leung, A M, Tang, P J, Johnson
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(7)
The purpose of this Phase II study was to determine the response rate, the toxicity, and the effect on survival of the combination of cisplatin, doxorubicin, 5-fluorouracil, and alpha-IFN (PIAF) in advanced unresectable hepatocellular carcinoma. Fift
Publikováno v:
The cancer journal from Scientific American. 4(4)
Taxol (paclitaxel) represents a new class of anticancer agent with activity against a wide variety of solid tumors. It has been found to be active in patients with adenocarcinoma and squamous cell carcinoma of the esophagus. To determine its activity
Publikováno v:
Therapiekonzepte Onkologie ISBN: 9783540638216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::252bb21ae763e4d1be2eaf2c48fe08a2
https://doi.org/10.1007/978-3-662-10493-4_30
https://doi.org/10.1007/978-3-662-10493-4_30
Publikováno v:
Oncology Reports.
Hepatic arterial infusion (HAI) of floxuridine is often used for metastatic colorectal cancer, though this is associated with dose-limiting hepatobiliary toxicity. A phase I trial was initiated to determine if circadian-patterned HAI floxuridine woul
Autor:
D. V. Jones, Y. Z. Patt
Publikováno v:
Therapiekonzepte Onkologie ISBN: 9783540585862
Fernmetastasen solider Tumoren sind — auch bei unilokularer Manifestation — als Hinweis auf eine systemische Tumorerkrankung anzusehen und konnen mittels Operation oder Radiotherapie nur selten kurativ behandelt werden. In einzelnen Fallen, in de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5af12a584a84901dd256dc438f15e068
https://doi.org/10.1007/978-3-662-10494-1_28
https://doi.org/10.1007/978-3-662-10494-1_28
Autor:
D V, Jones, Y Z, Patt, J A, Ajani, J, Abbruzzese, C H, Carrasco, C, Charnsangavej, B, Levin, S, Wallace
Publikováno v:
Cancer. 72(9)
Mitoxantrone is an anthraquinone derivative that has demonstrated encouraging preclinical and clinical activity against a variety of human carcinoma cell lines and malignancies. Three Phase II studies of systemically administered mitoxantrone in pati
Autor:
Y Z, Patt, D A, Podoloff, S, Curley, R, Smith, V A, Badkhamkar, L M, Lamki, M M, Jessup, D C, Hohn
Publikováno v:
Cancer. 71
In an effort to identify the site of recurrent colorectal cancer in patients with occult metastasis and increasing serum CEA levels, we conducted two trials using monoclonal antibodies (MoAb) against CEA. The first utilized Indium-111-labeled ZCE-025